Your browser doesn't support javascript.
loading
Performance of antenatal imaging to predict placenta accreta spectrum degree of severity.
Morel, Olivier; van Beekhuizen, Heleen J; Braun, Thorsten; Collins, Sally; Pateisky, Petra; Calda, Pavel; Henrich, Wolfgang; Al Naimi, Ammar; Norgaardt, Lone Nikoline; Chalubinski, Kinga M; Sentilhes, Loic; Tutschek, Boris; Schwickert, Alexander; Stefanovic, Vedran; Bertholdt, Charline.
Afiliação
  • Morel O; Women's Division, Nancy Regional University Hospital (CHRU), Université de Lorraine, and Diagnosis and International Adaptive Imaging (IAD), Inserm, Université de Lorraine, Nancy, France.
  • van Beekhuizen HJ; Department of Gynecological Oncology, Erasmus MC Cancer center, Rotterdam, The Netherlands.
  • Braun T; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Collins S; Department of Obstetrics, Berlin Institute of Health, Berlin, Germany.
  • Pateisky P; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK and the Fetal Medicine Unit, John Radcliffe Hospital, Oxford, UK.
  • Calda P; Division of Obstetrics and Feto-Maternal Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Henrich W; Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Al Naimi A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Norgaardt LN; Department of Obstetrics and Gynecology, Buergerhospital - Dr. Senckenberg Foundation, Frankfurt, Germany.
  • Chalubinski KM; Department of Obstetrics and Gynecology, University Hospital of the Goethe University of Frankfurt, Frankfurt, Germany.
  • Sentilhes L; Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Tutschek B; Division of Obstetrics and Feto-Maternal Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Schwickert A; Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France.
  • Stefanovic V; Praenatal-Zuerich and Medical Faculty Heinrich Heine University, Duesseldorf, Germany.
  • Bertholdt C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Acta Obstet Gynecol Scand ; 100 Suppl 1: 21-28, 2021 03.
Article em En | MEDLINE | ID: mdl-33811333
ABSTRACT

INTRODUCTION:

In cases of placenta accreta spectrum, a precise antenatal diagnosis of the suspected degree of invasion is essential for the planning of individual management strategies at delivery. The aim of this work was to evaluate the respective performances of ultrasonography and magnetic resonance imaging for the antenatal assessment of the severity of placenta accreta spectrum disorders included in the database. The secondary objective was to identify descriptors related to the severity of placenta accreta spectrum disorders. MATERIAL AND

METHODS:

All the cases included in the database for which antenatal imaging data were available were analyzed. The rates of occurrence of each ultrasound and magnetic resonance imaging descriptor were reported and compared between the Group "Accreta-Increta" (FIGO grades 1 & 2) and the Group "Percreta" (FIGO grade 3).

RESULTS:

Antenatal imaging data were available for 347 women (347/442, 78.5%), of which 105 were included in the Group "Accreta - Increta" (105/347, 30.2%) and 213 (213/347, 61.4%) in the Group "Percreta". Magnetic resonance imaging was performed in addition to ultrasound in 135 women (135/347, 38.9%). After adjustment for all ultrasound descriptors in multivariate analysis, only the presence of a bladder wall interruption was associated with a significant higher risk of percreta (Odds ratio 3.23, Confidence interval 1.33-7.79). No magnetic resonance imaging sign was significantly correlated with the degree of severity.

CONCLUSIONS:

The performance of ultrasound and magnetic resonance imaging to discriminate mild from severe placenta accreta spectrum disorders is very poor. To date, the benefit of additional magnetic resonance imaging has not been demonstrated.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placenta Acreta / Diagnóstico Pré-Natal / Índice de Gravidade de Doença / Imageamento por Ressonância Magnética / Ultrassonografia Pré-Natal Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy País/Região como assunto: America do norte / Europa Idioma: En Revista: Acta Obstet Gynecol Scand Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placenta Acreta / Diagnóstico Pré-Natal / Índice de Gravidade de Doença / Imageamento por Ressonância Magnética / Ultrassonografia Pré-Natal Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy País/Região como assunto: America do norte / Europa Idioma: En Revista: Acta Obstet Gynecol Scand Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França